Primary hyperaldosteronism differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Primary hyperaldosteronism}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Primary_hyperaldosteronism]]
{{CMG}}; {{AE}} {{HK}}


==Overview==
==Overview==
Primary hyperaldosteronism must be differentiated from other diseases that cause [[hypertension]] and [[hypokalemia]] such as [[renal artery stenosis]], [[cushing's syndrome]], [[congenital adrenal hyperplasia]], [[Liddle's syndrome]], [[diuretic]] use, [[licorice]] ingestion and [[renin-secreting tumors]].
Primary hyperaldosteronism must be differentiated from other diseases that cause [[hypertension]] and [[hypokalemia]], such as [[renal artery stenosis]], [[cushing's syndrome]], [[congenital adrenal hyperplasia]], [[Liddle's syndrome]], [[diuretic]] use, [[licorice]] ingestion, and [[renin-secreting tumors]].


==Differentiating Primary Hyperaldosteronism from other Diseases==
==Differentiating Primary Hyperaldosteronism from other Diseases==
Line 16: Line 17:
*[[Licorice]] ingestion
*[[Licorice]] ingestion
*[[Renin]]-secreting [[Tumor|tumors]]
*[[Renin]]-secreting [[Tumor|tumors]]
{{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01=Hypertension and Hypokalemia}}
{{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01=[[Hypertension]] and [[Hypokalemia]]}}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | B01 | | | | | |B01=Plasma renin activity}}
{{familytree | | | | | | | | | B01 | | | | | |B01=[[Plasma renin activity]]}}
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }}
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }}
{{familytree | | C01 | | | | | | | | | | | |C02|C01=Normal or High (Plasma Renin/Aldosterone ratio <10|C02=Suppressed (Plasma Renin/Aldosterone ratio >20}}
{{familytree | | C01 | | | | | | | | | | | |C02|C01=Normal or High (Plasma [[Renin]]/[[Aldosterone]] ratio <10)|C02=Suppressed (Plasma [[Renin]]/[[Aldosterone]] ratio > 20)}}
{{familytree | | |!| | | | | | | | | | | | | |!| }}
{{familytree | | |!| | | | | | | | | | | | | |!| }}
{{familytree | | D01 | | | | | | | | | | | |D02|D01=*Renin-secreting tumors<br>*Diuretic use<br>*Renovascular hypertension<br>*Coarctation of aorta<br>*Malignant phase hypertension|D02=Urinary aldosterone}}
{{familytree | | D01 | | | | | | | | | | | |D02|D01=• [[Renin-secreting tumors]]<br>• [[Diuretic]] use<br>• [[Renovascular hypertension]]<br>• [[Coarctation of aorta]]<br>• [[Malignant hypertension]]|D02=Urinary [[aldosterone]]}}
{{familytree | | | | | | | | | | | | |,|-|-|-|+|-|-|-|-|.|}}
{{familytree | | | | | | | | | | | | |,|-|-|-|+|-|-|-|-|.|}}
{{familytree | | | | | | | | | | | | E01 | | E02 | | | E03 |E01=Elevated|E02=Normal|E03=Low|}}
{{familytree | | | | | | | | | | | | E01 | | E02 | | | E03 |E01=Elevated|E02=Normal|E03=Low|}}
{{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }}
{{familytree | | | | | | | | | | | | |!| | | |!| | | | |!| | }}
{{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=Conn's syndrome (Primary aldosteronism)|F02=Profound K+ depletion|F03=• 17 alpha hydroxylase deficiency<br>• 11 beta hydroxylase deficiency<br>• Liddle's syndrome<br>• Licorice ingestion<br>• Deoxycortisone producing tumor|}}
{{familytree | | | | | | | | | | | | F01 | | F02 | | | F03 |F01=Conn's syndrome (Primary aldosteronism)|F02=Profound [[sodium|K]] depletion|F03=• [[17 alpha hydroxylase deficiency]]<br>• [[11 beta hydroxylase deficiency]]<br>• [[Liddle's syndrome]]<br>• [[Licorice]] ingestion<br>• Deoxycortisone producing tumor|}}
{{familytree | | | | | | | | | | | | | | | | | | | | | |!| | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | |!| | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | |G01|G01=Add Mineralocrticoid antagonist for 8 weeks}}
{{familytree | | | | | | | | | | | | | | | | | | | | |G01|G01=Add Mineralocrticoid antagonist for 8 weeks}}
{{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|-|.}}
{{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|-|-|-|-|-|-|.}}
{{familytree | | | | | |H01| | | | | | | | | | | | | | | | | | | | | | | | | | | |H02|H01=BP response|H02=No BP response}}
{{familytree | | | | | |H01| | | | | | | | | | | | | | | | | | | | | | | | | | | |H02|H01=[[blood pressure|BP]] response|H02=No [[blood pressure|BP]] response}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree | | | | | |I01| | | | | | | | | | | | | | | | | | | | | | | | | | | |I02|I01=• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)<br>• Licorice ingestion<br>•Glucocorticoid resistance|I02=Liddle's syndrome)|}}
{{familytree | | | | | |I01| | | | | | | | | | | | | | | | | | | | | | | | | | | |I02|I01=• [[Deoxycorticosterone]] excess ([[Tumor]], [[17 alpha hydroxylase deficiency|17 alpha hydroxylase]], and [[11 beta hydroxylase deficiency]])<br>• [[Licorice]] ingestion<br>• [[Glucocorticoid]] resistance|I02=[[Liddle's syndrome]]|}}
{{familytree/end}}
{{familytree/end}}


Line 39: Line 40:
|+
|+
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnoses}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Differential Diagnoses}}
! colspan="10" align="center" style="background:#4479BA; color: #FFFFFF; width: 400px;" + | Clinical features
! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF; width: 400px;" + | Clinical features
!
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History Findings}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History Findings}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory Findings}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory Findings}}
|-
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Headache and hypertension
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnoses
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nausea and vomiting
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hypertension
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nausea and Vomiting
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Palpitations
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Palpitations
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Shortness of breath
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Shortness of breath
Line 53: Line 51:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fatigue
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fatigue
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constipation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constipation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Visual Abnormalities
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pruritis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pruritis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Polyuria
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ambiguous genitalia
!Ambiguous genitalia
|as
|as
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Renin-Secreting tumors]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Renin-secreting tumors|Renin-Secreting tumors]]
| style="padding: 5px 5px; background: #F5F5F5;" | ✔
| style="padding: 5px 5px; background: #F5F5F5;" | ✔


(Due to hypertension)
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |
|<nowiki>-</nowiki>
* Drug-resistant [[hypertension]]
|
* Chronic [[Headache|headaches]]
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* Drug-resistant hypertension
* Chronic headaches
|
* Normal [[renal function tests]]
* Normal [[renal function tests]]
* Normal [[liver function tests]]
* Normal [[liver function tests]]
* [[Metabolic alkalosis]] (pH > 7.45)
* [[Metabolic alkalosis]] (pH > 7.45)
* [[Hyperkalemia]]  
* [[Hypokalemia]]  
* [[Plasma]] [[renin]]-[[aldosterone]] ratio <10
* [[Plasma]] [[renin]]-[[aldosterone]] ratio <10
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Coarctation of aorta]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Coarctation of aorta]]
| style="padding: 5px 5px; background: #F5F5F5;" | ✔  
| style="padding: 5px 5px; background: #F5F5F5;" | ✔  
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" | -
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |
|
|
*Young patients ([[neonates]]) may have history of:
*Young patients ([[neonates]]) may have history of:
** [[Failure to thrive]]
** [[Failure to thrive]]
** Poor feeding
** [[Poor feeding]]
** Lethargy
** [[Lethargy]]
** [[Turner syndrome|Turner's syndrome]]
** [[Turner syndrome|Turner's syndrome]]
** Familial predisposition
** Familial predisposition
Line 107: Line 96:
** [[Claudication]]
** [[Claudication]]
** [[Epistaxis]]
** [[Epistaxis]]
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Bicuspid aortic valves]]
* [[Bicuspid aortic valves]]
* Notching of [[ribs]]
* Notching of [[ribs]]
Line 116: Line 105:
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |[[11β-hydroxylase deficiency|11-beta hydroxylase deficiency]]
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |[[11β-hydroxylase deficiency|11-beta hydroxylase deficiency]]
| style="padding: 5px 5px; background: #F5F5F5;" | ✔ ([[Hypertensive crisis]] due to increased [[11-deoxycorticosterone]]-11-DOC)
| style="padding: 5px 5px; background: #F5F5F5;" | ✔ ([[Hypertensive crisis]] due to increased [[11-deoxycorticosterone]]-11-DOC)
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
|<nowiki>✔</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>✔</nowiki>
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" |✔
| -
| style="padding: 5px 5px; background: #F5F5F5;" |
|<nowiki></nowiki>
|
* Females:
* Females:
** [[Clitoral body|Clitoral]] enlargement
** [[Clitoral body|Clitoral]] enlargement
Line 133: Line 120:
** [[Penis|Penile]] enlargement
** [[Penis|Penile]] enlargement
* (If not diagnosed at birth, may present as premature [[adrenarche]], developing body odor with [[Axillary hair|axillary]] and [[pubic hair]] development)
* (If not diagnosed at birth, may present as premature [[adrenarche]], developing body odor with [[Axillary hair|axillary]] and [[pubic hair]] development)
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* Hypokalemia
* Hypokalemia
* Increased 11-DOC levels
* Increased 11-DOC levels
* Increased androgens  
* Increased [[androgens]]
* Low [[urinary]] [[aldosterone]] level
* Low [[urinary]] [[aldosterone]] level
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |[[17 alpha-hydroxylase deficiency|17-alpha hydroxylase deficiency]]
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |[[17 alpha-hydroxylase deficiency|17-alpha hydroxylase deficiency]]
| style="padding: 5px 5px; background: #F5F5F5;" | ✔
| style="padding: 5px 5px; background: #F5F5F5;" | ✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
|<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" | -
| -
| style="padding: 5px 5px; background: #F5F5F5;" |✔
| -
| style="padding: 5px 5px; background: #F5F5F5;" |
|<nowiki></nowiki>
|
* [[Phenotypically]] females at birth
* [[Phenotypically]] females at birth
* Lack of [[pubertal]] development in females
* Lack of [[pubertal]] development in females
* Incompletely developed external [[genitalia]] in males
* Incompletely developed external [[genitalia]] in males
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* Increased [[serum]] [[mineralocorticoids]]
* Increased [[serum]] [[mineralocorticoids]]
* Decreased [[androgen]] levels
* Decreased [[androgen]] levels
Line 161: Line 146:
* Low [[urinary]] [[aldosterone]] level
* Low [[urinary]] [[aldosterone]] level
|-
|-
|'''[[Uremia]]'''
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''[[Uremia]]'''
| -✔
| style="padding: 5px 5px; background: #F5F5F5;" |
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
| -
| style="padding: 5px 5px; background: #F5F5F5;" | -
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |✔
| -
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|✔
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
| -
| style="padding: 5px 5px; background: #F5F5F5;" |
| -
|
* Patients have [[chronic kidney disease]] and maybe on [[dialysis]]
* Patients have [[chronic kidney disease]] and maybe on [[dialysis]]
* Features of uremic neuropathy:
* Features of uremic neuropathy:
Line 183: Line 166:
** Delayed [[Deep tendon reflex|deep tendon reflexes]]
** Delayed [[Deep tendon reflex|deep tendon reflexes]]
** [[Muscle wasting]]
** [[Muscle wasting]]
* [[Encephalopathy]]
** [[Encephalopathy]]
|
| style="padding: 5px 5px; background: #F5F5F5;" |
* Increased [[blood urea nitrogen]] ([[Blood urea nitrogen|BUN]]) and [[creatinine]] ([[Cr]])
* Increased [[blood urea nitrogen]] ([[Blood urea nitrogen|BUN]]) and [[creatinine]] ([[Cr]])
* [[Hyperkalemia]]
* [[Hyperkalemia]]
* Decreased [[serum]] [[Vitamin D3|vitamin 1,25 dihydroxy vitamin D3]] level
* Decreased [[serum]] [[Vitamin D3|vitamin 1,25 dihydroxy vitamin D3]] level
|-
|-
|[[Liddle's syndrome|'''Liddle's syndrome''']]  
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |[[Liddle's syndrome|'''Liddle's syndrome''']]  
|
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|
| style="padding: 5px 5px; background: #F5F5F5;" |✔
|
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|
| style="padding: 5px 5px; background: #F5F5F5;" |<nowiki>-</nowiki>
|
| style="padding: 5px 5px; background: #F5F5F5;" |
|
* [[Family history]] of [[Liddle's syndrome]] ([[autosomal dominant inheritance]])
|
* [[Nephropathy]]
|
* [[Arrythmias]]
* [[SCNN1B]] or [[SCNN1G]] [[gene mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Hyporeninemic hypoaldosteronism]]
* [[Hypertension]]
* [[Hypokalemia]]
* Enhanced [[erythrocyte]] [[sodium]] influx 
* Low [[urinary]] [[aldosterone]]
|}
|}



Latest revision as of 19:31, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Primary hyperaldosteronism must be differentiated from other diseases that cause hypertension and hypokalemia, such as renal artery stenosis, cushing's syndrome, congenital adrenal hyperplasia, Liddle's syndrome, diuretic use, licorice ingestion, and renin-secreting tumors.

Differentiating Primary Hyperaldosteronism from other Diseases

Primary hyperaldosteronism (PA) should be differentiated from other diseases causing hypertension and hypokalemia for example:[1][1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]

 
 
 
 
 
 
 
 
Hypertension and Hypokalemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma renin activity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal or High (Plasma Renin/Aldosterone ratio <10)
 
 
 
 
 
 
 
 
 
 
 
Suppressed (Plasma Renin/Aldosterone ratio > 20)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Renin-secreting tumors
Diuretic use
Renovascular hypertension
Coarctation of aorta
Malignant hypertension
 
 
 
 
 
 
 
 
 
 
 
Urinary aldosterone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elevated
 
Normal
 
 
Low
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conn's syndrome (Primary aldosteronism)
 
Profound K depletion
 
 
17 alpha hydroxylase deficiency
11 beta hydroxylase deficiency
Liddle's syndrome
Licorice ingestion
• Deoxycortisone producing tumor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Add Mineralocrticoid antagonist for 8 weeks
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BP response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No BP response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deoxycorticosterone excess (Tumor, 17 alpha hydroxylase, and 11 beta hydroxylase deficiency)
Licorice ingestion
Glucocorticoid resistance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liddle's syndrome
Differential Diagnoses Clinical features History Findings Laboratory Findings
Headache and hypertension Nausea and vomiting Palpitations Shortness of breath Diminished pulses Fatigue Constipation Pruritis Ambiguous genitalia
Renin-Secreting tumors - - - - -
Coarctation of aorta - - -
11-beta hydroxylase deficiency ✔ (Hypertensive crisis due to increased 11-deoxycorticosterone-11-DOC) - - - -
17-alpha hydroxylase deficiency - - - - -
Uremia - -
Liddle's syndrome - - - - -

References

  1. 1.0 1.1 Wada N, Jin S, Hui SP, Yanagisawa K, Kurosawa T, Chiba H (2014). "[Differential diagnosis of primary aldosteronism by measurement of hybrid steroids using mass spectrometry]". Rinsho Byori (in Japanese). 62 (3): 276–82. PMID 24800505.
  2. Nielsen ML, Pareek M, Andersen I (2012). "[Liquorice-induced hypertension and hypokalaemia]". Ugeskr. Laeg. (in Danish). 174 (15): 1024–5. PMID 22487411.
  3. Chow KM, Ma RC, Szeto CC, Li PK (2012). "Polycystic kidney disease presenting with hypertension and hypokalemia". Am. J. Kidney Dis. 59 (2): 270–2. doi:10.1053/j.ajkd.2011.08.020. PMID 21962616.
  4. Sarafidis PA, Georgianos PI, Germanidis G, Giavroglou C, Nikolaidis P, Lasaridis AN, Madias NE (2012). "Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis". Am. J. Kidney Dis. 59 (3): 434–8. doi:10.1053/j.ajkd.2011.11.001. PMID 22154539.
  5. Khosla N, Hogan D (2006). "Mineralocorticoid hypertension and hypokalemia". Semin. Nephrol. 26 (6): 434–40. doi:10.1016/j.semnephrol.2006.10.004. PMID 17275580.
  6. Weiner ID (2013). "Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism". Semin. Nephrol. 33 (3): 265–76. doi:10.1016/j.semnephrol.2013.04.007. PMC 3748390. PMID 23953804.
  7. Martell-Claros N, Abad-Cardiel M, Alvarez-Alvarez B, García-Donaire JA, Pérez CF (2015). "Primary aldosteronism and its various clinical scenarios". J. Hypertens. 33 (6): 1226–32. doi:10.1097/HJH.0000000000000546. PMID 25715092.
  8. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB (2000). "Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program". Hypertension. 35 (5): 1025–30. PMID 10818057.
  9. Rossi E, Farnetti E, Nicoli D, Sazzini M, Perazzoli F, Regolisti G, Grasselli C, Santi R, Negro A, Mazzeo V, Mantero F, Luiselli D, Casali B (2011). "A clinical phenotype mimicking essential hypertension in a newly discovered family with Liddle's syndrome". Am. J. Hypertens. 24 (8): 930–5. doi:10.1038/ajh.2011.76. PMID 21525970.
  10. Ruecker B, Lang-Muritano M, Spanaus K, Welzel M, l'Allemand D, Phan-Hug F, Katschnig C, Konrad D, Holterhus PM, Schoenle EJ (2015). "The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants". Horm Res Paediatr. 84 (1): 43–8. doi:10.1159/000381852. PMID 25968592.
  11. Ardhanari S, Kannuswamy R, Chaudhary K, Lockette W, Whaley-Connell A (2015). "Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension". Adv Chronic Kidney Dis. 22 (3): 185–95. doi:10.1053/j.ackd.2015.03.002. PMID 25908467.
  12. Iglesias P, Tajada P, Martínez I, Díez JJ (2009). "[Salt-wasting congenital adrenal hyperplasia associated to hyperreninemic hyperaldosteronism]". Med Clin (Barc) (in Spanish; Castilian). 132 (2): 80–1. doi:10.1016/j.medcli.2008.09.002. PMID 19174076.
  13. Kikuta Y, Sanjo K, Nakajima K, Ashizawa I, Ojima M (1988). "Primary aldosteronism in childhood due to primary adrenal hyperplasia". Tohoku J. Exp. Med. 155 (1): 57–70. PMID 3413779.
  14. Hassan-Smith Z, Stewart PM (2011). "Inherited forms of mineralocorticoid hypertension". Curr Opin Endocrinol Diabetes Obes. 18 (3): 177–85. doi:10.1097/MED.0b013e3283469444. PMID 21494136.
  15. Bartter FC, Henkin RI, Bryan GT (1968). "Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia". J. Clin. Invest. 47 (8): 1742–52. doi:10.1172/JCI105864. PMC 297334. PMID 4299011.

Template:WH Template:WS